Ablynx Banks $200M IPO in Nasdaq Debut Post author:Sam Post published:October 24, 2017 Post category:BioPharma Ablynx announced the price of its U.S. IPO at $17.50. Source: BioSpace You Might Also Like GenKyoTex S.A. Provides Business Update For Q1 2017 April 26, 2017 REGENXBIO Banks on Strong Gene Therapy Pipeline and Potential Partnerships January 8, 2018 The FDA Calls Kyowa Hakko Kirin's Lymphoma Drug a Breakthrough August 24, 2017
